IRDAI commission-cap proposal hits PB Fintech, Turtlemint shares
PB Fintech fell 33.02% and Turtlemint 34.97% after IRDAI proposed caps on health-insurance commissions. Jefferies estimates a 10% cut in new-business commissions could reduce PB Fintech earnings by 10%-12%.
What happened
PB Fintech (Policybazaar) · Proposed IRDAI commission and expense caps triggered sharp declines in PB Fintech and Turtlemint, pressuring digital
Key facts
- PB Fintech shares fell 33.02% to ₹1,165.50; market capitalisation ₹53,933.83 Cr
- Turtlemint fell 34.97% to ₹87.30
- IRDAI proposes 15% commission cap on new individual health policies and 5% on renewals/portability
- Jefferies estimates a 10% new-business commission cut could lower PB Fintech earnings by 10%-12%
- Zelio plans ₹167.95 Cr fundraising and targets 550 dealerships by FY27
- Nykaa and L’Oréal BOLD will acquire minority stakes in Indian beauty and wellness brands
Why this matters
Lower commission pools may accelerate consolidation and partnership activity among insurtech distributors, insurers and embedded-insurance platforms seeking scale, proprietary demand and lower acquisition costs.